1. Home
  2. CLGN vs PCLA Comparison

CLGN vs PCLA Comparison

Compare CLGN & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLGN
  • PCLA
  • Stock Information
  • Founded
  • CLGN 2004
  • PCLA 2008
  • Country
  • CLGN Israel
  • PCLA Japan
  • Employees
  • CLGN N/A
  • PCLA N/A
  • Industry
  • CLGN Industrial Specialties
  • PCLA Building Products
  • Sector
  • CLGN Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • CLGN Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • CLGN 22.1M
  • PCLA 32.3M
  • IPO Year
  • CLGN N/A
  • PCLA 2025
  • Fundamental
  • Price
  • CLGN $3.18
  • PCLA $0.58
  • Analyst Decision
  • CLGN Strong Buy
  • PCLA
  • Analyst Count
  • CLGN 2
  • PCLA 0
  • Target Price
  • CLGN $11.50
  • PCLA N/A
  • AVG Volume (30 Days)
  • CLGN 165.3K
  • PCLA 257.7K
  • Earning Date
  • CLGN 05-28-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • CLGN N/A
  • PCLA N/A
  • EPS Growth
  • CLGN N/A
  • PCLA N/A
  • EPS
  • CLGN N/A
  • PCLA N/A
  • Revenue
  • CLGN $2,472,000.00
  • PCLA $5,475,228.00
  • Revenue This Year
  • CLGN $2,177.67
  • PCLA N/A
  • Revenue Next Year
  • CLGN $56.52
  • PCLA N/A
  • P/E Ratio
  • CLGN N/A
  • PCLA N/A
  • Revenue Growth
  • CLGN N/A
  • PCLA 40.19
  • 52 Week Low
  • CLGN $1.55
  • PCLA $0.37
  • 52 Week High
  • CLGN $5.63
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • CLGN 59.91
  • PCLA N/A
  • Support Level
  • CLGN $1.90
  • PCLA N/A
  • Resistance Level
  • CLGN $4.98
  • PCLA N/A
  • Average True Range (ATR)
  • CLGN 0.40
  • PCLA 0.00
  • MACD
  • CLGN 0.25
  • PCLA 0.00
  • Stochastic Oscillator
  • CLGN 47.52
  • PCLA 0.00

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: